Influence of methylprednisolone on levels of neuron-specific enolase in cardiac surgery: a corticosteroid derivative...

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Cerebral injury is a known complication of cardiac surgery with cardiopulmonary bypass (CPB).
• Neuron-specific enolase (NSE) and S-100beta protein are biomarkers for detecting neuronal damage post-CPB.
• Corticosteroids possess anti-inflammatory properties that may mitigate CPB-induced systemic effects.

Purpose of the Study:

• To investigate the effect of corticosteroids on serum neuron-specific enolase (NSE) levels.
• To determine if methylprednisolone administration reduces biochemical markers of neuronal injury after CPB.

Main Methods:

• Thirty patients undergoing elective coronary bypass surgery were randomly assigned to a control group or a methylprednisolone group (1 gm pre-CPB).
• Serum samples were collected pre-CPB and at 4 and 24 hours post-CPB for analysis of NSE, IL-6, and IL-10.
• Standard coronary bypass surgery was performed on the control group without additional medication.

Main Results:

• Serum NSE and IL-6 levels increased significantly in both groups post-CPB.
• The methylprednisolone group showed significantly reduced IL-6 and NSE levels compared to the control group.
• Interleukin-10 (IL-10) levels were higher in the methylprednisolone group post-CPB, and high NSE correlated with IL-6 in the control group.

Conclusions:

• Methylprednisolone administration may help decrease neuronal damage during heart surgery, as indicated by lower NSE levels.
• Further research is needed to confirm the neuroprotective effects and clinical outcomes.
• The study did not demonstrate an adverse neurological outcome in the methylprednisolone group.